Saturday - September 19, 2026
Goodwin Guides Dualitas Therapeutics on Research Collaboration With Roche to Discover and Develop Novel Bispecific Antibodies for I&I Diseases
September 17, 2026
BOSTON, Massachusetts, Sept. 17 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:

* * *

Goodwin Guides Dualitas Therapeutics on Research Collaboration With Roche to Discover and Develop Novel Bispecific Antibodies for I&I Diseases

*

The Life Sciences team advised Dualitas Therapeutics, Inc. ("Dualitas") on a research collaboration and license agreement with Roche to advance novel bispecific antibo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products